Chantilly BioPharma, LLC is a specialty pharmaceutical company, formed in conjunction with this acquisition, and focused on the development and commercialization of generic and branded pharmaceutical products into the Retail and Non-Retail Market Segments. Key to Chantilly BioPharma’s strategy will be the utilization of the acquired intellectual property to achieve superior solutions for our customers. In addition to the development and commercialization of its own products, Chantilly BioPharma will provide product development and production Lab Services, as well as Contract Manufacturing Services, including clinical and commercial production to third party Branded and Generic Pharmaceutical Companies.